| ALDH | Aldehyde dehydrogenase |
| AMPK | AMP-activated protein kinase |
| ARH1 | Aplasia Ras homolog member I |
| ATG | Autophagy-related |
| BER | Basic excision repair (BER) |
| BM | Bone marrow |
| BM-MSCs | Bone marrow mesenchymal stem cells |
| BC | Breast cancer |
| BCSC | Breast cancer stem cells |
| C.B-17/Icr-scid/scidJc1mice | Severe combined immunodeficient mice |
| CQ | Chloroquine |
| CSCs | Cancer stem cells |
| DMFS | Distant metastasis-free survival |
| DNMT1 | DNA methyltransferase 1 |
| DTCs | Disseminated tumour cells |
| EC | Endothelial cell |
| ECM | Extracellular matrix |
| EDG2 | Lysophosphatidic acid receptor |
| ELEANORS | ESR1 locus enhancing and activating non-coding RNAs |
| EMT | Epithelial to mesenchymal transition |
| EphA5 | Eph receptor 5 |
| ER | Oestrogen receptor |
| FTIs | Farnesyl transferase inhibitors |
| HER2 | Human epidermal growth factor receptor 2 |
| IGF-1 | Insulin growth factor-1 |
| LncRNAs | Long non-coding RNAs |
| MALAT1 | Metastasis-associated lung adenocarcinoma transcript 1 |
| MHC | Major histocompatibility complex |
| miRNAs | Micro RNAs |
| MMC | Mouse mammary carcinoma |
| MMTV-PyMT | mouse mammary tumour virus-polyoma middle tumour-antigen |
| MRD | Minimal residual disease |
| NETs | Neutrophil extracellular traps |
| OS | Overall survival |
| Pfkfb3 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 |
| PR | Progesterone receptor |
| PTX | Pentoxifylline |
| ROS | Reactive oxygen species |
| SIM | Simvastatin |
| TET | Ten-eleven translocation |
| TME | Tumour microenvironment |
| TNBC | Triple-negative breast cancer |
| TRAIL | TNF-alpha-Related Apoptosis-Inducing Ligand |
| TSP1 | Thrombospondin-1 |